Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Reexamination Certificate
2006-01-10
2006-01-10
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
C424S243100, C424S237100, C424S234100, C424S184100, C424S831000, C424S823000, C424S824000, C424S825000
Reexamination Certificate
active
06984381
ABSTRACT:
A novel vaccine for immunizing animals againstStaphylococcus aureus-induced mastitis is disclosed. The vaccine is comprised of whole killed cells ofS. aureusin a dosage effective to immunize an animal against the organism, in combination with a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4197290 (1980-04-01), Yoshida
patent: 4327082 (1982-04-01), Armitage
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4748020 (1988-05-01), von Malsen-Ponickau
patent: 4762712 (1988-08-01), Stolle et al.
patent: 5032522 (1991-07-01), Watson
patent: 5198214 (1993-03-01), Stolle et al.
patent: 5571514 (1996-11-01), Hook et al.
patent: 5679349 (1997-10-01), Scheifinger et al.
patent: 5770208 (1998-06-01), Fattom et al.
patent: 5980908 (1999-11-01), Hook et al.
patent: 6194161 (2001-02-01), Fattom et al.
patent: 6291431 (2001-09-01), Balaban et al.
patent: 6294177 (2001-09-01), Fattom
patent: WO 98/10788 (1998-03-01), None
R. A. Almeida et al., “Staphylococcus aureusInvasion of Bovine Mammary Epithelial Cells”,J. Dairy Sci., vol. 79, (6) pp. 1021-1026, 1996.
E. Cifrian et al., “Adherence ofStaphylococcus aureusto Cultured Bovine Mammary Epithelial Cells1”,J. Dairy Sci., vol. 77, (4) pp. 970-983, 1994.
A. Guidry et al., “Serotyping scheme forStaphylococcus aureusisolated from cows with mastitis”,AJVR, vol. 59, (12), pp. 1537-1540, Dec. 1998.
A. Guidry et al., “Prevalence of capsular serotypes amongStaphylococcus aureusisolates from cows with mastitis in the United States”,Veterinary Microbiology, vol. 59, pp. 53-58, 1997.
C. N. O'Brien et al., “Immunization withStaphylococcus aureusLysate Incorporated into Microspheres1”,J. Dairy Sci., vol. 84, (8), pp. 1791-1799, 2001.
C. N. O'Brien et al., “Production of Antibodies toStaphylococcus aureusSerotypes 5, 8, and 336 Using Poly (DL-Lactide-CO-Glycolide) Microspheres1”,J. Dairy Sci., vol. 83, (8),pp. 1758-1766, 2000.
T. Tollersrud et al., “Genetic and Serologic Evaluation of Capsule Production by Bovine Mammary Isolates ofStaphylococcus aureusand otherStaphylococcusspp. from Europe and the United States”,Journal of Clinical Microbiology, vol. 38 (8), pp. 2998-3003, Aug. 2000.
Guidry Albert
O'Brien Celia
Devi S.
Fado John D.
Rabin Evelyn M.
The United States of America as represented by the Secretary of
LandOfFree
Vaccine for the prevention of bacterial infection of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine for the prevention of bacterial infection of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for the prevention of bacterial infection of the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3557877